Afeyan: Flagship started four platform projects alongside Moderna's foundation
Noubar Afeyan · Moderna and Flagship Pioneering: Noubar Afeyan · Oct 11, 2021 · at 43:07
Noubar Afeyan, founder of Flagship Pioneering and co-founder of Moderna, explains their portfolio model to Guy Raz.
0:00 / 0:17exact quote · 17.9s
720p mp4 · rendered on demand · StarZero watermark
“In the exact same year that we Did the foundation laying for what became Moderna. We also started four other projects that were each platforms in their own right, going after different aspects of biomedical opportunity space, each with as big a leap, each with as much doubt”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Noubar Afeyan
Afeyan: The romantic 'hero founder' startup folklore is largely unnecessary
“There's a lot of folklore in the startup world, which I'd say emphasizes the role of the individual. There's a hero kind of notion that's created, you know, against all odds. And here we were claiming that conceiving, creating, growing companies could be the o…”
Afeyan: Precision in guessing what works is unimportant when pioneering new fields
“The accuracy with which you have to guess what's going to work Is not at all important. Because we get into these brand new areas, it's wide open to find where value lies, right? Imagine if we waited three, four years as people did, or 10 years in the case of …”
Afeyan: Long biotech lifecycles prevent serial entrepreneurship, forcing internal talent creation
“In biotech, these companies have a half-life or a life cycle of, say, 10 years, 15 years. So people don't do one company after another. If they do one company after 1015 years and they succeed, they stop doing it. So you have to create the talent.”
Afeyan: Nobody took mRNA research seriously as recently as 2016
“Five years ago, nobody was taking MRNA research seriously”